MNMD

Mind Medicine MindMed Inc
3.48
0.10 (2.96%)
Company Name Stock Ticker Symbol Market Type
Mind Medicine MindMed Inc MNMD NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.10 2.96% 3.48 14:52:07
Open Price Low Price High Price Close Price Prev Close
3.42 3.36 3.5801 3.38
more quote information »

Recent News

Date Time Source Heading
1/09/202316:32EDGARCurrent Report Filing (8-k)
1/09/202307:30PRNCAMindMed Provides Corporate Update and 2023 Outlook
12/22/202216:38EDGARStatement of Changes in Beneficial Ownership (4)
12/22/202216:33EDGARStatement of Changes in Beneficial Ownership (4)
12/01/202207:30PRNCAMindMed to Participate in the Canaccord Genuity New..
11/14/202208:08GLOBEActivist Investor Informs MindMed of Financial..
11/11/202207:30PRNCAMindMed to Participate in the Jefferies London Healthcare..
11/10/202208:22EDGARQuarterly Report (10-q)
11/10/202208:11EDGARCurrent Report Filing (8-k)
11/10/202208:05PRNCAMindMed Reports Third Quarter 2022 Financial Results and..
11/03/202208:08GLOBESignificant MindMed Investor Demands Federal Investigation..
11/03/202207:30PRNCAMindMed to Host Earnings Call to Discuss Third Quarter 2022..
10/18/202216:35EDGARStatement of Changes in Beneficial Ownership (4)
10/07/202217:16EDGARStatement of Ownership (sc 13g)
10/06/202213:34EDGARStatement of Ownership (sc 13g)
10/05/202208:35PRNUSMindMed to Participate in the Cantor Fitzgerald Neurology &..
10/04/202207:30PRNUSMindMed Collaborators Initiate Phase 1 Comparative PK/PD..
9/29/202216:30EDGARCurrent Report Filing (8-k)
9/29/202216:27EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
9/28/202215:52PRNUSMindMed Board is Trippin': Significant Investor Calls for..
9/27/202223:47PRNCAMindMed Announces Pricing of Public Offering of Common..
9/27/202218:40EDGARStatement of Changes in Beneficial Ownership (4)
9/27/202216:24EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
9/27/202216:17PRNUSMindMed Announces Proposed Public Offering of Common Shares
9/20/202207:30PRNCAMindMed Collaborators Dose First Patient in Phase 1..
9/19/202212:59EDGARStatement of Changes in Beneficial Ownership (4)
9/14/202208:01EDGARCurrent Report Filing (8-k)
9/14/202207:30PRNUSMindMed Announces Compliance with Nasdaq Listing..
9/08/202207:30PRNUSMindMed Announces Positive Results from Collaborators'..
9/07/202207:30PRNCAMindMed to Participate in H.C. Wainwright Global Investment..
9/01/202212:25EDGARStatement of Changes in Beneficial Ownership (4)
9/01/202212:17EDGARStatement of Changes in Beneficial Ownership (4)
8/26/202216:48EDGARCurrent Report Filing (8-k)
8/26/202216:30PRNUSMindMed Completes 1-for-15 Reverse Share Split
8/25/202207:30PRNCAMindMed Announces First Patient Dosed in Phase 2b Trial of..
8/17/202218:37EDGARStatement of Changes in Beneficial Ownership (4)
8/12/202207:30PRNCAMindMed Strengthens Board with Appointment of Two New..
8/11/202216:22EDGARQuarterly Report (10-q)
8/11/202216:06PRNCAMindMed Reports Second Quarter 2022 Financial Results and..
8/11/202216:04EDGARCurrent Report Filing (8-k)
8/11/202208:08PRNUSMindMed Co-Founder Dr. Scott Freeman Proposes Value..
8/04/202217:30PRNUSMindMed Board of Directors Approves Reverse Share Split
8/04/202207:30PRNCAMindMed to Host Earnings Call to Discuss Second Quarter 2022..
8/02/202207:30PRNUSMindMed to Participate in the Canaccord Genuity 42nd Annual..
7/27/202219:50EDGARStatement of Changes in Beneficial Ownership (4)
7/26/202213:23EDGARStatement of Changes in Beneficial Ownership (4)
7/21/202207:32EDGARCurrent Report Filing (8-k)
7/18/202218:35EDGARStatement of Changes in Beneficial Ownership (4)
6/30/202217:30PRNCAMindMed Announces Completion of Share Redesignation
6/30/202217:17EDGARCurrent Report Filing (8-k)